JP2024545170A5 - - Google Patents
Info
- Publication number
- JP2024545170A5 JP2024545170A5 JP2024534514A JP2024534514A JP2024545170A5 JP 2024545170 A5 JP2024545170 A5 JP 2024545170A5 JP 2024534514 A JP2024534514 A JP 2024534514A JP 2024534514 A JP2024534514 A JP 2024534514A JP 2024545170 A5 JP2024545170 A5 JP 2024545170A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence shown
- ch2ch2o
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2021/136994 WO2023102875A1 (en) | 2021-12-10 | 2021-12-10 | Anti-cdh6 antibody drug conjugate |
| CN202111507685 | 2021-12-10 | ||
| CNPCT/CN2021/136994 | 2021-12-10 | ||
| CN202111507685.5 | 2021-12-10 | ||
| PCT/CN2022/137932 WO2023104188A1 (en) | 2021-12-10 | 2022-12-09 | Anti-cdh6 antibodies and antibody-drug conjugates thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024545170A JP2024545170A (ja) | 2024-12-05 |
| JP2024545170A5 true JP2024545170A5 (enExample) | 2025-12-08 |
Family
ID=86729685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534514A Pending JP2024545170A (ja) | 2021-12-10 | 2022-12-09 | 抗ｃｄｈ６抗体及びその抗体薬物複合体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250090677A1 (enExample) |
| EP (1) | EP4444360A1 (enExample) |
| JP (1) | JP2024545170A (enExample) |
| KR (1) | KR20240130160A (enExample) |
| CN (1) | CN118302199A (enExample) |
| AU (1) | AU2022406708A1 (enExample) |
| CA (1) | CA3239715A1 (enExample) |
| IL (1) | IL313227A (enExample) |
| MX (1) | MX2024007035A (enExample) |
| TW (1) | TW202330618A (enExample) |
| WO (1) | WO2023104188A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024190815A1 (ja) | 2023-03-14 | 2024-09-19 | 第一三共株式会社 | 抗ｃｄｈ６抗体－薬物コンジュゲートとｖｅｇｆ阻害剤の組み合わせ |
| AU2024248799A1 (en) | 2023-03-31 | 2025-10-23 | Daiichi Sankyo Company, Limited | Combination of anti-CDH6 antibody-drug conjugate and HIF-2alpha inhibitor |
| WO2026082031A1 (zh) * | 2024-10-14 | 2026-04-23 | 先声再明医药股份有限公司 | 一种包含抗cdh6抗体或其adc的药物组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2939013T3 (es) * | 2015-04-20 | 2023-04-18 | Consejo Superior Investigacion | Agentes que se unen específicamente al motivo RGD de la cadherina 17 humana, la cadherina 5 humana, la cadherina 6 humana y la cadherina 20 humana |
| WO2018185618A1 (en) * | 2017-04-03 | 2018-10-11 | Novartis Ag | Anti-cdh6 antibody drug conjugates and anti-gitr antibody combinations and methods of treatment |
| TW202532104A (zh) * | 2017-05-15 | 2025-08-16 | 日商第一三共股份有限公司 | 抗體－藥物結合物及其用途 |
| SG11202104993SA (en) * | 2018-11-14 | 2021-06-29 | Daiichi Sankyo Co Ltd | Anti-cdh6 antibody-pyrrolobenzodiazepine derivative conjugate |
-
2022
- 2022-12-09 JP JP2024534514A patent/JP2024545170A/ja active Pending
- 2022-12-09 CN CN202280076590.9A patent/CN118302199A/zh active Pending
- 2022-12-09 US US18/715,982 patent/US20250090677A1/en active Pending
- 2022-12-09 EP EP22903605.8A patent/EP4444360A1/en active Pending
- 2022-12-09 CA CA3239715A patent/CA3239715A1/en active Pending
- 2022-12-09 TW TW111147444A patent/TW202330618A/zh unknown
- 2022-12-09 AU AU2022406708A patent/AU2022406708A1/en active Pending
- 2022-12-09 KR KR1020247022271A patent/KR20240130160A/ko active Pending
- 2022-12-09 IL IL313227A patent/IL313227A/en unknown
- 2022-12-09 WO PCT/CN2022/137932 patent/WO2023104188A1/en not_active Ceased
- 2022-12-09 MX MX2024007035A patent/MX2024007035A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3093327C (en) | Targeted cd73 antibody and antibody-drug conjugate, and preparation method therefor and uses thereof | |
| JP7133611B2 (ja) | 高いインビボ忍容性を有するアントラサイクリン系の抗体薬物複合体 | |
| US9828428B2 (en) | Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates | |
| JP2022101693A (ja) | 抗ｃｕｂドメイン含有タンパク質１（ｃｄｃｐ１）抗体、抗体薬物コンジュゲート、およびその使用方法 | |
| TW202146456A (zh) | 抗ｃｄ７１抗體類、可活化之抗ｃｄ７１抗體類及使用彼等之方法 | |
| JP2024545170A5 (enExample) | ||
| CN119233994A (zh) | Nectin-4结合剂 | |
| KR20200010491A (ko) | 항체-약물 접합체를 제조하기 위한 이중 접합 방법 | |
| CN106938051A (zh) | 靶向于组织因子的抗体‑药物偶联物 | |
| RU2019129839A (ru) | Производные майтанзиноида с саморасщепляющимися пептидными линкерами и их конъюгаты | |
| EP4130046A1 (en) | Platform for constructing multispecific antibody | |
| TW202233251A (zh) | 抗體藥物綴合物 | |
| CN114828895A (zh) | 制备基于艾日布林的抗体-药物缀合物的方法 | |
| CN110575548A (zh) | 靶向于cd73的抗体-药物偶联物及其制法和用途 | |
| IL313227A (en) | Anti-cdh6 antibodies and antibody-drug conjugates thereof | |
| CA3067380A1 (en) | Antibody-drug conjugates containing anti-globo h antibodies and uses thereof | |
| KR20250084935A (ko) | 링커-페이로드 화합물, 접합체 및 이의 응용 분야 | |
| CN105828841A (zh) | 抗-efna4抗体-药物缀合物 | |
| US20240091372A1 (en) | Anti-doppel antibody drug conjugates | |
| EP4725968A1 (en) | Anti-gpc3 antibody or antigen-binding fragment and use thereof | |
| JP2026512687A (ja) | ヒト化ｌ１ｃａｍ抗体－薬物複合体 | |
| CN118324916B (zh) | 一种抗人gprc5d的单克隆抗体及其制备方法和用途 | |
| CN120988123B (zh) | 一种抗人NaPi2b的人源化单克隆抗体及其应用 | |
| CN117430708B (zh) | 一种抗Claudin18.2抗体 | |
| US20250340636A1 (en) | Antibodies targeting l1cam and uses thereof |